Posted by Michael Wonder on 18 Dec 2019
PBS Growth Hormone Program - 1 January 2020 listing changes
18 December 2019 - Changes to the Pharmaceutical Benefits Scheme restrictions for growth hormone treatment (adult use), which set out the eligibility requirements for PBS subsidy, are being introduced on 1 January 2020.
On 1 January 2020, the adult listing will be amended to improve clarity and access for patients with childhood onset growth hormone deficiency (CO-GHD) due to congenital, genetic or structural cause.
This means that children may continue to access PBS subsidised growth hormone treatment as adults if they meet the PBS restriction criteria.
